The Credentialed Clinical Instructor Program Level 2 (CCIP Level 2), formerly the Advanced CCIP) is designed for physical therapists and physical therapist assistants who want to further develop their clinical teaching skills and construct a clinical curriculum. Using a case-based and interactive approach to education, this program will provide participants with the essential knowledge and skill to more effectively teach and mentor students in the context of a doctoring profession, across core areas of contemporary professional education and clinical practice that foster best clinical teaching. The program’s unique philosophy and design both applies and goes beyond the concepts of the APTA Credentialed Clinical Instructor Level 1 Program (CCIP Level 1) to l enable clinical educators to achieve the best outcomes for student learning.

The program is divided into three distinct parts:

1. Pre-course assignments that include reading four articles and completing three of the online Professionalism Modules.
2. Advanced clinical instructor education via an interactive face-to-face course format that is appropriate to all physical therapist clinical educators;
3. Assessment (credentialing) of curricula outcomes through an Assessment Center to apply information from the ACCIP.

These components are used together to first provide, and then assess, the knowledge and skill identified as essential for Advanced CIs.

Intended audience: Physical Therapists or Physical Therapist Assistants who have completed the APTA Credentialed Clinical Instructor Level 1 Program (CCIP Level 1) and have supervised at least one student in clinical practice, overseen the supervision of at least one student in clinical practice, or have been actively involved in student learning and education since becoming credentialed. As with the CCIP Level 1, eligible clinicians from other health care professions are welcome to participate and can earn CEUs for the program, although they will not be APTA credentialed.

Firm registration deadline: February 27, 2019

Date: April 8, 2019

Time: 5:30-7:30 pm

Location: 5850 E Still Circle Mesa, AZ 85206

Room: Cougar, 3rd Floor

Course description:

A discussion and demonstration will be provided on how the Otometrics Biologic AudX or AudX Pro otoacoustic emissions devices are utilized for pediatric and adult audiometric evaluation. Clinical considerations in use of otoacoustic emissions and types of otoacoustic emissions will be discussed. A step by step demonstration will also be provided. In addition, a discussion and demonstration of OAE assessment in the pediatric and adult population including considerations such as calibration, stimulus type and reporting results will be provided.

In addition, a discussion and demonstration will be provided on how various systems are utilized for evoked potentials such as ABR, ECochG and ASSR. The basics of evoked potentials will be reviewed along with a discussion of threshold assessment in both ABR and ASSR with hands-on practicum. The day will end with a review of frequently asked questions regarding all aspects of evoked potentials. The benefits of the use of evoked potentials to both the clinician and patient will be presented.

Patient database management will also be presented including integration with OTObase. OTObase is a tool utilized to integrate any NOAH compatible devices/applications into an Electronic Medical Record (EMR) system.

Learner outcome:

• Define anatomy related to generation of otoacoustic emissions
• Define types of otoacoustic emissions and their benefits: spontaneous, transient, distortion product OAEs
• Determine clinical applications of OAEs for different patient populations
• Determine troubleshooting strategies for improved OAE testing techniques
• Define unique features that improve testing efficiency with Biologic OAE testing equipment
• Demonstrate patient preparation and collection of auditory evoked potential data
• Troubleshoot and manipulate auditory evoked potential protocols as well as manage patient records

How to register:

Email: jason.faloon@natus.com or jeanette.fitzke@natus.com by April 1st, 2019.

CEU information:

Otometrics, a division of Natus, is approved by the American Academy of Audiology to offer Academy CEUs for this activity. The program is worth a maximum of 2  CEUs. Academy approval of this continuing education activity is based on course content only and does not imply endorsement of course content, specific products, or clinical procedure, or adherence of the event to the Academy’s Code of Ethics. Any views that are presented are those of the presenter/CE Provider and not necessarily of the American Academy of Audiology. This course is offered for up to .2 AAA CEUs.

Speaker Bio:

Jeanette Fitzke, AuD, joined Otometrics, division of Natus, in February 2015 as the West Regional Field Clinical Audiologist where she has trained several providers and given multiple local, state and national presentations and lectures on a variety of Audiology, Vestibular, Telehealth, and Business related topics pertinent to the hearing and balance healthcare industry. She has 17 years of clinical experience in such settings as ENT, hospital, and multi-specialty clinics where she worked with a variety of age populations and focused on diagnostics, hearing aid services, vestibular care, and electrophysiological testing. She obtained her B.S. from the University of Arizona, M.S. from Arizona State University and AuD from A.T. Still University. She is currently a member of the American Speech Hearing Association and American Academy of Audiology and holds her Clinical Certificate of Competency in Audiology

Facilitated by:

Jeanette Fitzke, AuD, CCC-A

Field Clinical Audiologist/Team Lead (Western US & Canada)

Otometrics (Division of Natus)

Jason Faloon

District Sales Manager: CO, AZ, NM, S. NV, El Paso

Otometrics (Division of Natus)

About Otometrics:
Otometrics, a division of Natus, is the audiology industry leader. For more than 50 years, Otometrics has been helping hearing and balance care professionals improve the quality of life for their clients and patients by delivering expert knowledge, reliable solutions and services and trusted partnership.

Otometrics develops, manufactures and markets audiological, otoneurologic and vestibular instrumentation in more than 80 countries under the Otometrics brands, including Madsen®, Aurical®, ICS®, Oscilla®, Otoscan® and Bio-logic®. Otometrics is a strategic business unit of Natus Medical Incorporated (North America NASDAQ: BABY) — a US-based leading provider of healthcare products, devices and services used in the newborn, neurology, sleep, hearing and balance markets. For more information, please visit www.otometrics.com or www.natus.com.

More courses available at: www.otometrics.us/education

Course Description: 

The goal of this one-day course is to demystify the processes of physical therapy examination, evaluation and intervention in the coprehensive care of individuals with multiple sclerosis (MS). The course will cover the most current evidence and practice in the management of MS. The course will involve lecture, discussion, patient case study and live demonstration of strategies for implementation in the clinic.

Course Objectives:

At completion of this course, the participant will be able to:

• Describe the etiology, epidemiology, pathophysiology, signs and symptoms, diagnosis, and course of multiple sclerosis (MS).
• Describe elements of the medical management of patients with MS.
• Identify and describe the examination procedures used to inform the evaluation of patients with MS to establish the physical therapy diagnosis, prognosis, and plan of care.
• Describe the role of the physical therapist in the management of persons with MS in terms of direct interventions and patient/client-related instruction to maximize function and quality of life.

Course Instructors:

Maria Rundell, PT, DPT, Board Certified Specialist in Neurologic Physical Therapy, Multiple Sclerosis Certified Specialist;

Sergio Rodriguez, MBA, MAEd, National Multiple Sclerosis Society

Registration Fees: $195.00 or $160.00 for ATSU Alumni, Clincal Instructors with ATSU students, or groups of 3 or more from one organization.

Contact Hours: 8 Contact Hours or .8 CEU’s

2019 ATSU Alaska CME/CE Cruise

Exploring Hot Topics in Primary Care

June 14-21, 2019

Click MORE for program information and tuition pricing.

ROYAL CARIBBEAN – OVATION OF THE SEAS | 7-night | Alaska Glacier Cruise
Cruise Departure: Seattle, Washington
Itinerary: Seattle, Washington | Alaska Inside Passage | Juneau, Alaska | Skagway, Alaska | Endicott Arm & Dawes Glacier |
                     Victoria, British Columbia | Seattle, Washington

SAVE THE DATE! 
Mark your calendars and plan to attend!

Evidence-Based Content: It is the policy of the ATSU to ensure that the content contained in this CME activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias.

ATSU Disclosure Policy: All persons in a position to control the content of an educational activity (i.e., activity planners, CESC, presenters, faculty, authors) participating in an educational activity provided by the ATSU are required to disclose to the provider any relevant financial relationships with any commercial interest. ATSU must determine if the individual’s relationships may influence the educational content and resolve any conflicts of interest prior to the commencement of the educational activity. The intent of this disclosure is not to prevent individuals with relevant financial relationships from participating, but rather to provide learners information with which they can make their own judgments.

Disclosure Statement: It is the policy of the ATSU Continuing Education Department to ensure balance, independence, objectivity and scientific rigor in all its educational programs.  Faculty disclosures will be made in the course syllabus and/or during faculty introductions.  The audience is advised that one or more presentations in this continuing education activity may contain references of unlabeled or unapproved uses of drugs or devices.

Resolution/Mechanism of Identified Conflict of Interest: Independent sources of review include the following: All disclosures will be reviewed by the program/course directors, CE Assistant Vice President, or CE Director for identification of conflicts of interest. Reviewers, working with the program directors will document the mechanism(s) for management and resolution of the conflict of interest and final approval of the activity will be documented prior to implementation. Any of the mechanisms below can/will be used to resolve conflict of interest:

• • • Peer review for valid, evidence-based content of all materials associated with an educational activity by the course/program director
    • Limit content to evidence with no recommendations
    • Introduction of a debate format with an unbiased moderator (point-counterpoint)
    • Inclusion of moderated panel discussion
    • Publication of a parallel or rebuttal article for an article that is felt to be biased
    • Limit equipment representatives to providing logistics and operation support only in procedural demonstrations
    • Divestiture of the relationship by faculty-The reviewer should be a physician or other scientist with knowledge of the specialty area being reviewed and often times the Assistant Vice President of Continuing Education will perform this first review and can then appoint an independent reviewer.-The independent reviewer is not be involved in the planning of this CME Activity and cannot have a relationship with any corporate entity supporting the CME activity.-The reviewer should have a copy of this policy and a copy of the Standards for Commercial Support to fully grasp their responsibilities as the reviewer. Off-Label or Unapproved Use of Drugs or Devices

It is the policy of the ATSU to require the disclosure of all references to off-label or unapproved uses of drugs or devices prior to the presentation of educational content. The audience is advised that this continuing medical education activity may contain reference(s) to off-label or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses.

Disclaimer: The opinions and recommendations expressed by the presenters and planners of educational content in this program are their own and do not necessarily represent the viewpoint of the ATSU.

Consent to Use of Photographic Images: Registration and attendance at or participation in ATSU meetings and other activities constitutes an agreement by the registrant to ATSU’s use and distribution (both now and in the future) of the registrant or attendee’s image or voice in photographs, videotapes, electronic reproductions, and audiotapes of such events and activities.

Audio, Video and Photographic Equipment: The use of audio, video and other photographic recording equipment by attendees is prohibited inside ATSU meeting rooms.

Reproduction Permission: Reproduction of written materials developed for this ATSU course is prohibited without the written permission from individual authors and ATSU.

Special Assistance: ATSU complies with the Americans with Disabilities Act §12112(a). If any participant is in need of special assistance or has any dietary restrictions, please see the CE staff at the registration desk or call 660.626.2232 for assistance.

Sponsored by the Orthopedic Physical Therapy Residency program at A.T. Still University  in conjunction with the Physical Therapy Department in the Arizona School of Health Sciences.

The Orthopedic Physical Therapy Residency program is accredited by the American Board of Physical Therapy Residency & Fellowship Education (ABPTRFE).

Course Instructor: Colin Rigney, PT, DPT, OCS, RMSK and Wayne Smith, PT, DPT. ATC, SCS, RMSK

Course Description: Do you want to know the what medical teams at the Olympics, Professional and Collegiate teams, even the International Space Station, are using to give them an edge in treatment? A.T. Still University is presenting an introductory two-part seminar in clinical applications of using musculoskeletal ultrasound imaging. The morning session will cover introduction to musculoskeletal ultrasound imaging and pathology as well as a live demonstration of selected anatomical sites. The afternoon session will include lives scanning and lectures on the US instrumentation and physics, image optimization, how to scan commonly treated joints and the lumbar spine, identification of tendons, nerves, muscles, and ligaments.

Course Objectives:

1. Introduce the participants to ultrasound musculoskeletal images
2. Explain US physics and instrumentation of US equipment.
3. Identify when Sonography is indicated to assist in managing common conditions.
4. Understand what information can be derived from Sonography.
5. Be able to perform an ultrasound assessment on selected anatomical structures.

CEU: Participants are awarded 0.7 CEUs or 7 contact hours at the end of the course.

Cost: $175 APTA members;  $150 for non ATSU Alumni and Clinical Instructors

ATSU Physical Therapy Department is qualified to provide physical therapist continuing education courses and activities according to the Arizona State Board of Physical Therapy (Rule R4-24-402).

CEU courses and other post-professional programs offered at ATSU are not associated with the CAPTE accredited residential Doctor of Physical Therapy program.

Primary Care Update

Aug. 2-4, 2019

Click MORE for program information and tuition pricing.

SAVE THE DATE! 
Mark your calendars and plan to attend!

Evidence-Based Content: It is the policy of the ATSU to ensure that the content contained in this CME activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias.

ATSU Disclosure Policy: All persons in a position to control the content of an educational activity (i.e., activity planners, CESC, presenters, faculty, authors) participating in an educational activity provided by the ATSU are required to disclose to the provider any relevant financial relationships with any commercial interest. ATSU must determine if the individual’s relationships may influence the educational content and resolve any conflicts of interest prior to the commencement of the educational activity. The intent of this disclosure is not to prevent individuals with relevant financial relationships from participating, but rather to provide learners information with which they can make their own judgments.

Disclosure Statement: It is the policy of the ATSU Continuing Education Department to ensure balance, independence, objectivity and scientific rigor in all its educational programs.  Faculty disclosures will be made in the course syllabus and/or during faculty introductions.  The audience is advised that one or more presentations in this continuing education activity may contain references of unlabeled or unapproved uses of drugs or devices.

Resolution/Mechanism of Identified Conflict of Interest: Independent sources of review include the following: All disclosures will be reviewed by the program/course directors, CE Assistant Vice President, or CE Director for identification of conflicts of interest. Reviewers, working with the program directors will document the mechanism(s) for management and resolution of the conflict of interest and final approval of the activity will be documented prior to implementation. Any of the mechanisms below can/will be used to resolve conflict of interest:

• Peer review for valid, evidence-based content of all materials associated with an educational activity by the course/program director
• Limit content to evidence with no recommendations
• Introduction of a debate format with an unbiased moderator (point-counterpoint)
• Inclusion of moderated panel discussion
• Publication of a parallel or rebuttal article for an article that is felt to be biased
• Limit equipment representatives to providing logistics and operation support only in procedural demonstrations
• Divestiture of the relationship by faculty-The reviewer should be a physician or other scientist with knowledge of the specialty area being reviewed and often times the Assistant Vice President of Continuing Education will perform this first review and can then appoint an independent reviewer.-The independent reviewer is not be involved in the planning of this CME Activity and cannot have a relationship with any corporate entity supporting the CME activity.-The reviewer should have a copy of this policy and a copy of the Standards for Commercial Support to fully grasp their responsibilities as the reviewer. Off-Label or Unapproved Use of Drugs or Devices

It is the policy of the ATSU to require the disclosure of all references to off-label or unapproved uses of drugs or devices prior to the presentation of educational content. The audience is advised that this continuing medical education activity may contain reference(s) to off-label or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses.

Disclaimer: The opinions and recommendations expressed by the presenters and planners of educational content in this program are their own and do not necessarily represent the viewpoint of the ATSU.

Consent to Use of Photographic Images: Registration and attendance at or participation in ATSU meetings and other activities constitutes an agreement by the registrant to ATSU’s use and distribution (both now and in the future) of the registrant or attendee’s image or voice in photographs, videotapes, electronic reproductions, and audiotapes of such events and activities.

Audio, Video and Photographic Equipment: The use of audio, video and other photographic recording equipment by attendees is prohibited inside ATSU meeting rooms.

Reproduction Permission: Reproduction of written materials developed for this ATSU course is prohibited without the written permission from individual authors and ATSU.

Special Assistance: ATSU complies with the Americans with Disabilities Act §12112(a). If any participant is in need of special assistance or has any dietary restrictions, please see the CE staff at the registration desk or call 660-626-2232 for assistance.

Sponsored by the Orthopedic Physical Therapy Residency program at A.T. Still University  in conjunction with the Physical Therapy Department in the Arizona School of Health Sciences.

The Orthopedic Physical Therapy Residency program is accredited by the American Board of Physical Therapy Residency & Fellowship Education (ABPTRFE).

Course Instructor: Kathy Petkovsky, PT, CHT and the Orthopedic Physical Therapy Residency faculty

Course Description: Featured topics for the general orthopedic clinical practice, including tendinopathies, peripheral nerve entrapments, and fractures, this course emphasizes clinical reasoning developing the participants’ skills that can be applied Monday morning in the clinic. This course includes ample lab time with a strong instructor participant ratio.

Course Objectives:

At the conclusion of this course, participants will be able to:

1. Assess the elbow, wrist, and hand regions for common injuries and conditions.

2. Review current best evidence for examination and management of conditions in the region of the elbow, wrist, and hand.

3. Apply improved examination and intervention strategies.

CEU: Participants are awarded .7 CEUs or 7 contact hours at the end of the course.

Cost: $175; $150 for ATSU alumni and current Clinical Instructors

ATSU Physical Therapy Department is qualified to provide physical therapist continuing education courses and activities according to the Arizona State Board of Physical Therapy (Rule R4-24-402).

CEU courses and other post-professional programs offered at ATSU are not associated with the CAPTE accredited residential Doctor of Physical Therapy program.

Osteopathic Approach to Primary Care: Integrating OMM in the Management of Condition

Oct. 10-12, 2019

Click MORE for program information and tuition pricing.

SAVE THE DATE! 
Mark your calendars and plan to attend!

Evidence-Based Content: It is the policy of the ATSU to ensure that the content contained in this CME activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias.

ATSU Disclosure Policy: All persons in a position to control the content of an educational activity (i.e., activity planners, CESC, presenters, faculty, authors) participating in an educational activity provided by the ATSU are required to disclose to the provider any relevant financial relationships with any commercial interest. ATSU must determine if the individual’s relationships may influence the educational content and resolve any conflicts of interest prior to the commencement of the educational activity. The intent of this disclosure is not to prevent individuals with relevant financial relationships from participating, but rather to provide learners information with which they can make their own judgments.

Disclosure Statement: It is the policy of the ATSU Continuing Education Department to ensure balance, independence, objectivity and scientific rigor in all its educational programs.  Faculty disclosures will be made in the course syllabus and/or during faculty introductions.  The audience is advised that one or more presentations in this continuing education activity may contain references of unlabeled or unapproved uses of drugs or devices.

Resolution/Mechanism of Identified Conflict of Interest: Independent sources of review include the following: All disclosures will be reviewed by the program/course directors, CE Assistant Vice President, or CE Director for identification of conflicts of interest. Reviewers, working with the program directors will document the mechanism(s) for management and resolution of the conflict of interest and final approval of the activity will be documented prior to implementation. Any of the mechanisms below can/will be used to resolve conflict of interest:

• Peer review for valid, evidence-based content of all materials associated with an educational activity by the course/program director
• Limit content to evidence with no recommendations
• Introduction of a debate format with an unbiased moderator (point-counterpoint)
• Inclusion of moderated panel discussion
• Publication of a parallel or rebuttal article for an article that is felt to be biased
• Limit equipment representatives to providing logistics and operation support only in procedural demonstrations
• Divestiture of the relationship by faculty-The reviewer should be a physician or other scientist with knowledge of the specialty area being reviewed and often times the Assistant Vice President of Continuing Education will perform this first review and can then appoint an independent reviewer.-The independent reviewer is not be involved in the planning of this CME Activity and cannot have a relationship with any corporate entity supporting the CME activity.-The reviewer should have a copy of this policy and a copy of the Standards for Commercial Support to fully grasp their responsibilities as the reviewer. Off-Label or Unapproved Use of Drugs or Devices

It is the policy of the ATSU to require the disclosure of all references to off-label or unapproved uses of drugs or devices prior to the presentation of educational content. The audience is advised that this continuing medical education activity may contain reference(s) to off-label or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses.

Disclaimer: The opinions and recommendations expressed by the presenters and planners of educational content in this program are their own and do not necessarily represent the viewpoint of the ATSU.

Consent to Use of Photographic Images: Registration and attendance at or participation in ATSU meetings and other activities constitutes an agreement by the registrant to ATSU’s use and distribution (both now and in the future) of the registrant or attendee’s image or voice in photographs, videotapes, electronic reproductions, and audiotapes of such events and activities.

Audio, Video and Photographic Equipment: The use of audio, video and other photographic recording equipment by attendees is prohibited inside ATSU meeting rooms.

Reproduction Permission: Reproduction of written materials developed for this ATSU course is prohibited without the written permission from individual authors and ATSU.

Special Assistance: ATSU complies with the Americans with Disabilities Act §12112(a). If any participant is in need of special assistance or has any dietary restrictions, please see the CE staff at the registration desk or call 660-626-2232 for assistance.

Primary Care Update

Dec. 5-7, 2019

Click MORE for program information and tuition pricing.

SAVE THE DATE! 
Mark your calendars and plan to attend!

Evidence-Based Content: It is the policy of the ATSU to ensure that the content contained in this CME activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias.

ATSU Disclosure Policy: All persons in a position to control the content of an educational activity (i.e., activity planners, CESC, presenters, faculty, authors) participating in an educational activity provided by the ATSU are required to disclose to the provider any relevant financial relationships with any commercial interest. ATSU must determine if the individual’s relationships may influence the educational content and resolve any conflicts of interest prior to the commencement of the educational activity. The intent of this disclosure is not to prevent individuals with relevant financial relationships from participating, but rather to provide learners information with which they can make their own judgments.

Disclosure Statement: It is the policy of the ATSU Continuing Education Department to ensure balance, independence, objectivity and scientific rigor in all its educational programs.  Faculty disclosures will be made in the course syllabus and/or during faculty introductions.  The audience is advised that one or more presentations in this continuing education activity may contain references of unlabeled or unapproved uses of drugs or devices.

Resolution/Mechanism of Identified Conflict of Interest: Independent sources of review include the following: All disclosures will be reviewed by the program/course directors, CE Assistant Vice President, or CE Director for identification of conflicts of interest. Reviewers, working with the program directors will document the mechanism(s) for management and resolution of the conflict of interest and final approval of the activity will be documented prior to implementation. Any of the mechanisms below can/will be used to resolve conflict of interest:

• Peer review for valid, evidence-based content of all materials associated with an educational activity by the course/program director
• Limit content to evidence with no recommendations
• Introduction of a debate format with an unbiased moderator (point-counterpoint)
• Inclusion of moderated panel discussion
• Publication of a parallel or rebuttal article for an article that is felt to be biased
• Limit equipment representatives to providing logistics and operation support only in procedural demonstrations
• Divestiture of the relationship by faculty-The reviewer should be a physician or other scientist with knowledge of the specialty area being reviewed and often times the Assistant Vice President of Continuing Education will perform this first review and can then appoint an independent reviewer.-The independent reviewer is not be involved in the planning of this CME Activity and cannot have a relationship with any corporate entity supporting the CME activity.-The reviewer should have a copy of this policy and a copy of the Standards for Commercial Support to fully grasp their responsibilities as the reviewer. Off-Label or Unapproved Use of Drugs or Devices

It is the policy of the ATSU to require the disclosure of all references to off-label or unapproved uses of drugs or devices prior to the presentation of educational content. The audience is advised that this continuing medical education activity may contain reference(s) to off-label or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses.

Disclaimer: The opinions and recommendations expressed by the presenters and planners of educational content in this program are their own and do not necessarily represent the viewpoint of the ATSU.

Consent to Use of Photographic Images: Registration and attendance at or participation in ATSU meetings and other activities constitutes an agreement by the registrant to ATSU’s use and distribution (both now and in the future) of the registrant or attendee’s image or voice in photographs, videotapes, electronic reproductions, and audiotapes of such events and activities.

Audio, Video and Photographic Equipment: The use of audio, video and other photographic recording equipment by attendees is prohibited inside ATSU meeting rooms.

Reproduction Permission: Reproduction of written materials developed for this ATSU course is prohibited without the written permission from individual authors and ATSU.

Special Assistance: ATSU complies with the Americans with Disabilities Act §12112(a). If any participant is in need of special assistance or has any dietary restrictions, please see the CE staff at the registration desk or call 660-626-2232 for assistance.

Primary Care Update

Jan. 12-19, 2020

Click MORE for program information and tuition pricing.

ROYAL CARIBBEAN – Allure of the Seas
7-night | Western Caribbean
Cruise Departure: Fort Lauderdale, Florida
Ports: CocoCay, Bahamas | Cozumel, Mexico | Costa Maya, Mexico | Roatan, Honduras

SAVE THE DATE! 
Mark your calendars and plan to attend!

Evidence-Based Content: It is the policy of the ATSU to ensure that the content contained in this CME activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias.

ATSU Disclosure Policy: All persons in a position to control the content of an educational activity (i.e., activity planners, CESC, presenters, faculty, authors) participating in an educational activity provided by the ATSU are required to disclose to the provider any relevant financial relationships with any commercial interest. ATSU must determine if the individual’s relationships may influence the educational content and resolve any conflicts of interest prior to the commencement of the educational activity. The intent of this disclosure is not to prevent individuals with relevant financial relationships from participating, but rather to provide learners information with which they can make their own judgments.

Disclosure Statement: It is the policy of the ATSU Continuing Education Department to ensure balance, independence, objectivity and scientific rigor in all its educational programs.  Faculty disclosures will be made in the course syllabus and/or during faculty introductions.  The audience is advised that one or more presentations in this continuing education activity may contain references of unlabeled or unapproved uses of drugs or devices.

Resolution/Mechanism of Identified Conflict of Interest: Independent sources of review include the following: All disclosures will be reviewed by the program/course directors, CE Assistant Vice President, or CE Director for identification of conflicts of interest. Reviewers, working with the program directors will document the mechanism(s) for management and resolution of the conflict of interest and final approval of the activity will be documented prior to implementation. Any of the mechanisms below can/will be used to resolve conflict of interest:

• Peer review for valid, evidence-based content of all materials associated with an educational activity by the course/program director
• Limit content to evidence with no recommendations
• Introduction of a debate format with an unbiased moderator (point-counterpoint)
• Inclusion of moderated panel discussion
• Publication of a parallel or rebuttal article for an article that is felt to be biased
• Limit equipment representatives to providing logistics and operation support only in procedural demonstrations
• Divestiture of the relationship by faculty-The reviewer should be a physician or other scientist with knowledge of the specialty area being reviewed and often times the Assistant Vice President of Continuing Education will perform this first review and can then appoint an independent reviewer.-The independent reviewer is not be involved in the planning of this CME Activity and cannot have a relationship with any corporate entity supporting the CME activity.-The reviewer should have a copy of this policy and a copy of the Standards for Commercial Support to fully grasp their responsibilities as the reviewer. Off-Label or Unapproved Use of Drugs or Devices

It is the policy of the ATSU to require the disclosure of all references to off-label or unapproved uses of drugs or devices prior to the presentation of educational content. The audience is advised that this continuing medical education activity may contain reference(s) to off-label or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses.

Disclaimer: The opinions and recommendations expressed by the presenters and planners of educational content in this program are their own and do not necessarily represent the viewpoint of the ATSU.

Consent to Use of Photographic Images: Registration and attendance at or participation in ATSU meetings and other activities constitutes an agreement by the registrant to ATSU’s use and distribution (both now and in the future) of the registrant or attendee’s image or voice in photographs, videotapes, electronic reproductions, and audiotapes of such events and activities.

Audio, Video and Photographic Equipment: The use of audio, video and other photographic recording equipment by attendees is prohibited inside ATSU meeting rooms.

Reproduction Permission: Reproduction of written materials developed for this ATSU course is prohibited without the written permission from individual authors and ATSU.

Special Assistance: ATSU complies with the Americans with Disabilities Act §12112(a). If any participant is in need of special assistance or has any dietary restrictions, please see the CE staff at the registration desk or call 660-626-2232 for assistance.